MedTrace Logo

Effectiveness of a Digital Health Application for Primary Hypertension (Liebria)

NCT06243978 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 328

Last updated 2024-06-20

No results posted yet for this study

Summary

This clinical trial with 328 patients with primary hypertension aims to investigate the effectiveness of the self-guided digital application liebria for patients with primary hypertension.

Conditions

Interventions

BEHAVIORAL

liebria

Participants will receive access to the digital health intervention liebria in addition to TAU

OTHER

information brochure on hypertension

Participants will receive an information brochure on hypertension

Sponsors & Collaborators

  • University Hospital Schleswig-Holstein

    collaborator OTHER

  • Charite University, Berlin, Germany

    collaborator OTHER

  • Gaia AG

    lead INDUSTRY

Principal Investigators

  • Kamila Jauch-Chara, MD · University Hospital Schleswig-Holstein

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-02
Primary Completion
2025-04-15
Completion
2025-04-15

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06243978 on ClinicalTrials.gov